Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
09/2000
09/28/2000WO2000056316A1 Treatment of gallstones
09/28/2000WO2000056307A1 Treatment of hiatial hernia
09/28/2000WO2000056304A2 Anti-inflammatory uses of manzamines
09/28/2000WO2000056153A1 Oral low dose butyrate compositions
09/28/2000WO2000041545A3 Regulators of the pct or smoothened pathway, compositions and uses related thereto
09/28/2000WO2000035428A3 Tricyclic nitrogen heterocycles as pde iv inhibitors
09/28/2000WO2000023114A3 Polymer conjugates of interferon beta- 1a and their uses
09/28/2000WO2000022143A3 Protein kinase homologs
09/28/2000WO2000015793A3 Human gpcr proteins
09/28/2000CA2669512A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000CA2377383A1 Apoptosis related genes
09/28/2000CA2368416A1 Treatment of gallstones
09/28/2000CA2368210A1 50 human secreted proteins
09/28/2000CA2368187A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors
09/28/2000CA2368047A1 Chemokine receptor binding heterocyclic compounds
09/28/2000CA2367985A1 Tetrahydropyran derivatives and their use as therapeutic agents
09/28/2000CA2367963A1 Hydroxamic and carboxylic acid derivatives
09/28/2000CA2367866A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000CA2367620A1 47 human secreted proteins
09/28/2000CA2367488A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000CA2367048A1 Treatment with small peptides to effect antifibrotic activity
09/28/2000CA2367045A1 Treatment of certain cancers associated with weight gain
09/28/2000CA2367035A1 Treatment of hiatial hernia
09/28/2000CA2366650A1 Oral low dose butyrate compositions
09/28/2000CA2365255A1 Human tumor necrosis factor receptor tr9
09/28/2000CA2365247A1 49 human secreted proteins
09/28/2000CA2365244A1 Calanolides for inhibiting btk
09/28/2000CA2365243A1 Human transmembrane proteins
09/28/2000CA2365238A1 48 human secreted proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/27/2000EP1038872A1 4-Phenyl-4-heteroarylpiperdine derivatives as opioid receptor ligands
09/27/2000EP1038526A1 Treatment of functional disorders of the lower intestinal tract and subsequent visceral pain with moxonidine
09/27/2000EP1038016A2 Needle-free injection of formulated nucleic acid molecules
09/27/2000EP1038011A2 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system
09/27/2000EP1037999A1 Porphorymonas gingivalis polypeptides and nucleotides
09/27/2000EP1037985A1 Restin and methods of use thereof
09/27/2000EP1037983A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
09/27/2000EP1037915A1 Matrix-remodeling genes
09/27/2000EP1037894A1 Pharmaceuticals
09/27/2000EP1037887A1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
09/27/2000EP1037868A2 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS
09/27/2000EP1037660A1 ribB
09/27/2000EP1037654A1 ribA
09/27/2000EP1037635A1 Compounds and methods
09/27/2000EP1037634A1 Novel administration form comprising an acid-labile active compound
09/27/2000EP1037607A1 Novel suppository form comprising an acid-labile active compound
09/27/2000EP0918792B1 Dipeptide benzamidine as a kininogenase inhibitor
09/27/2000EP0575484B1 Composition comprising pdgf and dexamethasone for promoting tissue repair and regeneration
09/27/2000CN1268137A Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
09/27/2000CN1268135A Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters
09/27/2000CN1268133A 2-Aminopyridines containing fused ring substituents as NOS inhibitors
09/27/2000CN1268122A Branched alkoxy- substituted 2-aminopyridines as NOS inhibitors
09/27/2000CN1267544A Health care medicine powder for infant
09/27/2000CN1267511A Surface modified granular calcium carbonate
09/27/2000CN1056772C Plaster and agentia with Chinese herb medicines for carsickness
09/27/2000CN1056766C Instant electuary with Chinese herb medicines for treating colonitis
09/27/2000CN1056764C Medicated plaster for accelerating digestion
09/27/2000CN1056761C Chinese herb medicine for treating appendicitis and its preparing method
09/27/2000CN1056759C Traditional Chinese medicine preparation for prevention and treatment of hepatitis B
09/27/2000CN1056757C Method for producing instant pearl granule for treatment of aphtha
09/27/2000CN1056755C Medicine for curing hepatitis
09/27/2000CN1056753C Medicinal instant granules for treating pediatric anorexia
09/27/2000CN1056750C Nutrient health care oral liquid and its preparing method
09/26/2000US6124464 Mixing a substituted sulfinyl heterocyclic compound containing an imidazole moiety with an alkylamine base or ammonia and a magnesium salt.
09/26/2000US6124456 Adenosine antagonists
09/26/2000US6124354 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
09/26/2000US6124332 Metalloproteinase inhibitors
09/26/2000US6124329 Metalloproteinase inhibitors
09/26/2000US6124316 Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools
09/26/2000US6124313 Imidazopyridine azolidinones
09/26/2000US6124312 Heterocyclic compounds
09/26/2000US6124296 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
09/26/2000US6124294 Compounds having high affinity for dopamine d3 receptor; used to treat disorders which respond to dopamine d3 ligands
09/26/2000US6124263 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
09/26/2000US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides
09/26/2000US6123916 For treating disorders with an aetiology comprising or associated with excess of gh-secretion
09/21/2000WO2000055351A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000WO2000055350A1 Human cancer associated gene sequences and polypeptides
09/21/2000WO2000055332A2 Human regulators of intracellular phosphorylation
09/21/2000WO2000055321A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000WO2000055320A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000WO2000055200A1 50 human secreted proteins
09/21/2000WO2000055199A1 47 human secreted proteins
09/21/2000WO2000055180A2 Human lung cancer associated gene sequences and polypeptides
09/21/2000WO2000055177A2 49 human secreted proteins
09/21/2000WO2000055174A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides
09/21/2000WO2000055162A2 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
09/21/2000WO2000055159A2 Substituted aza-oxindole derivatives
09/21/2000WO2000055155A2 Heterocyclic compounds as adenosine deaminase inhibitors
09/21/2000WO2000055153A1 Amide derivatives
09/21/2000WO2000055152A1 Aromatic heterocyclic compounds as anti-inflammatory agents
09/21/2000WO2000055141A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000055129A1 Dithiocarbonimidate derivatives
09/21/2000WO2000055120A1 Amide derivatives
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000WO2000055109A1 Lipoxin compounds and their use
09/21/2000WO2000054800A1 Preventives/remedies for digestive diseases
09/21/2000WO2000054792A1 Drugs, foods, drinks and feeds containing cocoa component
1 ... 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 ... 1258